Contributor

Anita H. Clayton, MD

Interim Chair, Department of Psychiatry & Neurobehavioral Sciences; David C. Wilson Professor of Psychiatry; Professor of Clinical Obstetrics and Gynecology, University of Virginia School of Medicine

Interim Chair, Department of Psychiatry & Neurobehavioral Sciences<br /> David C. Wilson Professor of Psychiatry<br /> Professor of Clinical Obstetrics and Gynecology<br /> University of Virginia School of Medicine<br /> <br /> Anita Clayton’s research has melded women’s mental health and sexual function, primarily involving mood disorders associated with reproductive-life events in women, sexual dysfunction related to illness and medications, and treatment of sexual disorders. She developed and validated several sexual functioning assessment tools including the Changes in Sexual Functioning Questionnaire (CSFQ), available in more than 75 languages, the Sexual Interest and Desire Inventory (SIDI-F), and the Decreased Sexual Desire Screener (DSDS). She co-edited Women’s Mental Health: A Comprehensive Textbook, and is the author of Satisfaction: Women, Sex, and the Quest for Intimacy. She was President of the International Society for the Study of Women’s Sexual Health (ISSWSH), served as Co-Chair of the 3rd International Consultation on Sexual Medicine (Women’s Section) in 2009, and is a Vice-Chair for Women’s Sexual Health for the 4th ICSM to be held in Madrid, Spain in 2015. She is a contributing editor for the Journal of Sexual Medicine, serves on the editorial advisory board of the Journal of Sex & Marital Therapy and Women’s Health, and is on the Board of Directors of the American Society of Clinical Psychopharmacology. She recently was a discussant on In the Next Room: The Vibrator Play for Medical Center Hour.<br /> <br /> Current clinical research projects involve potential new treatments for hypoactive sexual desire disorder, sexual arousal disorder, orgasmic disorder, antidepressant-induced sexual dysfunction, and major depressive disorder.<br /> <br /> Financial Disclosure (last 12 months)<br /> October 2013<br /> <br /> Grants: Forest Research Institute, Inc., Palatin Technologies; Pfizer, Inc.; Takeda; Trimel Pharmaceuticals <br /> <br /> Advisory Board Fee/Consultant Fee: Apricus Biosciences, Inc.; Euthymics; Forest Research Institute, Inc.; Lundbeck; Palatin Technologies; Pfizer, Inc.; S1 Biopharmaceuticals, Inc.; Sprout Pharmaceuticals; Takeda Global Research & Development; Trimel Pharmaceuticals<br /> <br /> Royalties/Copyright: Ballantine Books/Random House; Changes in Sexual Functioning Questionnaire; Guilford Publications<br /> <br /> Shares/Restricted Stock Units: Euthymics; S1 Biopharmaceuticals, Inc.

icon_gotatip_29x28Created with Sketch. Got a tip?

Do you have info to share with HuffPost reporters? Here’s how.